21.10

3.83% -0.84

Seaport Therapeutics Inc (SPTX)

Overview News Price History Discussions Forecast

Seaport Therapeutics Inc stock is traded at $21.10, with a volume of 53,530. It is down -3.83% in the last 24 hours and up +9.27% over the past month. Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Previous Close:

$21.94

Open:

$22.06

24h Volume:

53,530

Relative Volume:

0.25

Market Cap:

$1.13B

Revenue:

Net Income/Loss:

P/E Ratio:

-29.31

EPS:

-0.7198

Net Cash Flow:

1W Performance:

+1.20%

1M Performance:

+9.27%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$20.98

$22.16

1-Week Range:

$19.92

$22.53

52-Week Range:

$14.85

$22.98

Seaport Therapeutics Inc Stock (SPTX) Company Profile

Name

Seaport Therapeutics Inc

Sector

Healthcare (1071)

Industry

Biotechnology (598)

Phone

617-807-4062

Address

6 TIDE STREET, BOSTON

Employee

Twitter

Next Earnings Date

2026-09-14

Latest SEC Filings

SPTX's Discussions on Twitter

Compare SPTX vs VRTX, REGN, ARGX, RVMD, ALNY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SPTX Seaport Therapeutics Inc	21.10	1.13B	0	0	0	-0.7198
VRTX Vertex Pharmaceuticals Inc	477.36	121.16B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	656.01	68.78B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	918.22	57.44B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	189.23	40.23B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	271.77	36.28B	4.29B	577.22M	641.34M	4.2086

Seaport Therapeutics Inc Stock (SPTX) Latest News

Jul 24, 2026

Seaport Therapeutics (SPTX) Earnings Date and Reports 2026 - MarketBeat

Jul 24, 2026

Enterprise value to EBITDA forward of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView

Jul 24, 2026

Jul 20, 2026

Q2 Earnings Forecast for SPTX Issued By HC Wainwright - MarketBeat

Jul 20, 2026

Jul 16, 2026

Seaport Therapeutics (NASDAQ:SPTX) Stock Rating Upgraded by HC Wainwright - MarketBeat

Jul 16, 2026

Jul 15, 2026

Seaport Therapeutics stock initiated at buy by H.C. Wainwright - Investing.com Canada

Jul 15, 2026

Seaport Therapeutics, Inc. (NASDAQ:SPTX) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Jul 15, 2026

Jul 11, 2026

SPTX Price Today: Seaport Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Jul 11, 2026

Jul 07, 2026

Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress - AOL.com

Jul 07, 2026

Wolfe Research Initiates Seaport Therapeutics(SPTX.US) With Hold Rating - Moomoo

Jul 07, 2026

Jul 04, 2026

Price to earnings forward of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView

Jul 04, 2026

Price to sales forward of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView

Jul 04, 2026

Jul 02, 2026